Literature DB >> 28234141

Anosmia: Differential diagnosis, evaluation, and management.

George A Scangas1, Benjamin S Bleier.   

Abstract

The ability to scrutinize our surroundings remains heavily dependent on the sense of smell. From the ability to detect dangerous situations such as fires to the recollection of a fond memory triggered by an odor, the advantages of an intact olfactory system cannot be overstated. Outcomes studies have highlighted the profound negative impact of anosmia and parosmia on the overall quality of life. The National Institute on Deafness and Other Communication Disorders estimates that ∼1.4% of the United States population experiences chronic olfactory dysfunction and smell loss. Efforts have focused on improving both the diagnosis of olfactory dysfunction through olfactory testing and improved reporting of treatment outcomes of olfactory training. The purpose of this article was to review the differential diagnosis, workup, and current treatment strategies of anosmia and smell disorders.

Entities:  

Mesh:

Year:  2017        PMID: 28234141     DOI: 10.2500/ajra.2017.31.4403

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN: 1945-8932            Impact factor:   2.467


  14 in total

Review 1.  The role of metals in mammalian olfaction of low molecular weight organosulfur compounds.

Authors:  Eric Block; Victor S Batista; Hiroaki Matsunami; Hanyi Zhuang; Lucky Ahmed
Journal:  Nat Prod Rep       Date:  2017-05-10       Impact factor: 13.423

2.  Anosmia: an evidence-based approach to diagnosis and management in primary care.

Authors:  Peter G Deutsch; Catherine Evans; Nur Wahidah Wahid; Aakash D Amlani; Aman Khanna
Journal:  Br J Gen Pract       Date:  2021-02-25       Impact factor: 6.302

Review 3.  Epigenetic Treatment of Neurodegenerative Ophthalmic Disorders: An Eye Toward the Future.

Authors:  Walter H Moos; Douglas V Faller; Ioannis P Glavas; David N Harpp; Michael H Irwin; Iphigenia Kanara; Carl A Pinkert; Whitney R Powers; Kosta Steliou; Demetrios G Vavvas; Krishna Kodukula
Journal:  Biores Open Access       Date:  2017-12-01

4.  A New Approach to Treating Neurodegenerative Otologic Disorders.

Authors:  Walter H Moos; Douglas V Faller; Ioannis P Glavas; David N Harpp; Michael H Irwin; Iphigenia Kanara; Carl A Pinkert; Whitney R Powers; Kosta Steliou; Demetrios G Vavvas; Krishna Kodukula
Journal:  Biores Open Access       Date:  2018-07-01

5.  Prevalence of subjective impairments of the sense of smell and taste in employees of retirement and nursing homes during SARS-CoV-2 pandemic.

Authors:  Frederic Jungbauer; Lena Huber; Anne Lammert; Sonja Ludwig; Nicole Rotter; Lena Zaubitzer; Angela Schell
Journal:  Nurs Open       Date:  2021-10-02

Review 6.  "Anosmia" the mysterious collateral damage of COVID-19.

Authors:  Abdulrahman K Ahmed; Reem Sayad; Islam A Mahmoud; Aya M Abd El-Monem; Salma H Badry; Islam H Ibrahim; Mahmoud Hr Hafez; Mohamed A El-Mokhtar; Ibrahim M Sayed
Journal:  J Neurovirol       Date:  2022-03-05       Impact factor: 2.643

7.  Neuropsychological Symptom Identification and Classification in the Hospitalized COVID-19 Patients During the First Wave of the Pandemic in a Front-Line Spanish Tertiary Hospital.

Authors:  Juan D Molina; Irene Rodrigo Holgado; Alba Juanes González; Carolina Elisa Combarro Ripoll; David Lora Pablos; Gabriel Rubio; Jordi Alonso; Francisco P J Rivas-Clemente
Journal:  Front Psychiatry       Date:  2022-03-02       Impact factor: 4.157

Review 8.  Olfactory dysfunction in aging and neurodegenerative diseases.

Authors:  Xiuli Dan; Noah Wechter; Samuel Gray; Joy G Mohanty; Deborah L Croteau; Vilhelm A Bohr
Journal:  Ageing Res Rev       Date:  2021-07-27       Impact factor: 11.788

9.  Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?

Authors:  Simone Meini; Andrea Zanichelli; Rodolfo Sbrojavacca; Federico Iuri; Anna Teresa Roberts; Chiara Suffritti; Carlo Tascini
Journal:  Front Immunol       Date:  2020-08-11       Impact factor: 7.561

Review 10.  Loss of Olfactory Function-Early Indicator for Covid-19, Other Viral Infections and Neurodegenerative Disorders.

Authors:  Heike Rebholz; Ralf J Braun; Dennis Ladage; Wolfgang Knoll; Christoph Kleber; Achim W Hassel
Journal:  Front Neurol       Date:  2020-10-26       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.